Maeda et al. showed that fractal analysis of 11C-MET PET in patients with newly diagnosed GBM could differentiate low-grade glioma and glioblastoma as well as indicated the IDH1 mutation status [39]. This evidence concerns the gene IDH1 and glioblastoma.